Ozempic Shortage 2026: Alternatives and What to Do

The Ozempic shortage in 2026 continues to affect patients across the United States, leaving many unable to fill their prescriptions or facing significant delays. If you're struggling to get your Ozempic prescription filled, you're not alone — supply constraints have affected semaglutide-based medications intermittently since 2022, and demand continues to outpace manufacturing capacity. This guide covers the current shortage status, why it's happening, and practical alternatives and strategies to keep your treatment on track.

Current Ozempic Shortage Status (2026)

As of early 2026, certain doses of Ozempic remain in limited supply across various regions. The shortage has primarily affected:

• Ozempic 0.25 mg and 0.5 mg starter doses: Intermittent availability
• Ozempic 1.0 mg: Limited supply in many pharmacies
• Ozempic 2.0 mg: Availability varies by location
• Wegovy (semaglutide for weight management): Also experiencing supply constraints at certain dose levels

The FDA maintains a drug shortage database that tracks the current status of affected medications. Check with your local pharmacy for the most up-to-date availability in your area.

Why Is There an Ozempic Shortage?

Several factors have contributed to the ongoing supply challenges:

Unprecedented Demand

The explosive growth in GLP-1 medication prescriptions has far exceeded initial manufacturing projections. Prescriptions for semaglutide-based products have grown dramatically since 2020, driven by:

• Increased awareness of GLP-1 medications for weight loss
• Social media and celebrity attention
• Expanding FDA-approved indications
• Growing clinical evidence supporting their use
• Off-label prescribing for weight management

Manufacturing Complexity

Semaglutide is a complex biological molecule that requires sophisticated manufacturing processes:

• Production involves fermentation, purification, and formulation steps
• Scaling up production takes years, not months
• Quality control requirements are rigorous
• Raw material supply chains are global and interconnected

Global Supply Dynamics

Novo Nordisk, the sole manufacturer of Ozempic, has been investing billions in expanding production capacity, including:

• New manufacturing facilities in Denmark and the United States
• Expanded capacity at existing sites
• Investment in raw material supply chains

However, new facilities take several years to become fully operational, meaning supply may continue to lag demand in the near term.

What to Do If You Can't Get Ozempic

Step 1: Check Multiple Pharmacies

Don't give up after one pharmacy says they're out of stock. Try:

• Different pharmacy chains (CVS, Walgreens, Rite Aid, etc.)
• Independent pharmacies — they sometimes have different supply channels
• Mail-order pharmacies — may have different inventory
• Specialty pharmacies — particularly for injectable medications
• Hospital outpatient pharmacies — occasionally have separate supply lines

Step 2: Ask About Partial Fills

Some pharmacies can provide a partial fill of your prescription — giving you enough medication to bridge a gap while they wait for resupply. Ask your pharmacist if this option is available.

Step 3: Contact Novo Nordisk Directly

Novo Nordisk has resources to help patients find available supply:

• Patient assistance hotline: Can help locate pharmacies with inventory
• NovoCare program: May offer assistance with access and affordability
• Your provider's office: May have samples or connections to specialty pharmacies

Step 4: Talk to Your Healthcare Provider About Alternatives

This is the most important step. Your provider can evaluate alternative medications and adjust your treatment plan.

Alternative GLP-1 Medications

If Ozempic is unavailable, several alternatives may be appropriate depending on your situation:

For Diabetes Patients

Mounjaro (tirzepatide)

• Dual GLP-1/GIP receptor agonist
• FDA-approved for type 2 diabetes
• May produce equal or greater weight loss than Ozempic
• Weekly injection
• Different manufacturer (Eli Lilly), so supply may be independent of Ozempic

Rybelsus (oral semaglutide)

• Same active ingredient as Ozempic in pill form
• FDA-approved for type 2 diabetes
• May be more readily available since demand is lower
• Daily dosing with specific administration requirements

Trulicity (dulaglutide)

• GLP-1 receptor agonist approved for type 2 diabetes
• Weekly injection
• Less weight loss than semaglutide, but effective for blood sugar control
• Generally more available than semaglutide products

Victoza (liraglutide 1.8 mg)

• GLP-1 receptor agonist approved for type 2 diabetes
• Daily injection
• Well-established safety record
• More available but less effective for weight loss

For Weight Management Patients

Zepbound (tirzepatide)

• FDA-approved for weight management
• May produce greater weight loss than Wegovy/Ozempic
• Different manufacturer and supply chain

Saxenda (liraglutide 3.0 mg)

• FDA-approved for weight management
• Daily injection
• Less effective for weight loss but generally more available

Compounded Semaglutide

• Available through compounding pharmacies during shortage periods
• Generally less expensive than brand-name products
• Quality and regulation vary by pharmacy
• Discuss with your provider before using compounded versions

Compounded Semaglutide: What You Need to Know

During shortage periods, compounded semaglutide has become a popular alternative. Important considerations:

What Is Compounded Semaglutide?

Compounding pharmacies create custom formulations using semaglutide sodium (a salt form of semaglutide). These are not FDA-approved products but can be legally produced during shortage periods under specific regulations.

Potential Advantages

• Lower cost: Often $200–$500/month vs. $1,000+ for brand-name
• Availability: Not subject to the same supply constraints as Ozempic
• Dose flexibility: Can be customized to specific doses

Potential Risks

• Quality variation: Not all compounding pharmacies meet the same standards
• No FDA approval: The specific formulation hasn't been through FDA review
• Purity concerns: Some compounded products have been found to contain impurities
• Regulatory uncertainty: FDA regulations around compounded GLP-1s are evolving

How to Choose a Safe Compounding Pharmacy

If you pursue compounded semaglutide, look for:

• 503B outsourcing facility status: These pharmacies meet higher regulatory standards
• Third-party testing: Certificate of analysis for each batch
• Licensed and accredited: State board of pharmacy licensing and PCAB accreditation
• Provider oversight: Requires a legitimate prescription and medical supervision

Strategies for Managing During Shortages

Don't Skip Doses Without Guidance

If you're unable to fill your prescription, contact your provider before skipping doses. They may recommend:

• Temporary dose reduction to stretch remaining supply
• Switching to an available alternative
• Bridging strategies to minimize treatment gaps

Stock Up Strategically (Within Reason)

When your medication is available:

• Fill prescriptions as soon as they're eligible for refill
• Ask about 90-day supply options through mail-order pharmacies
• Set up auto-refill with your pharmacy

Set Up Pharmacy Notifications

Many pharmacies can notify you when a medication comes back in stock:

• Sign up for text or email alerts at your pharmacy
• Ask to be put on a waiting list
• Check pharmacy apps for real-time inventory

Consider Telehealth Platforms

Some telehealth providers specializing in GLP-1 medications have established supply relationships and may offer better access:

• They may source from pharmacies with dedicated GLP-1 inventory
• Some bundle medication with their service for streamlined access

What NOT to Do During an Ozempic Shortage

Don't Buy from Unverified Sources

The shortage has fueled a market for counterfeit and illegally imported medications. Avoid:

• Online pharmacies without proper licensing — may sell counterfeit products
• Social media sellers — no quality assurance
• International imports without a prescription — may be counterfeit, improperly stored, or mislabeled
• Sharing medications with family or friends

Don't Adjust Doses on Your Own

Resist the temptation to ration your medication by taking lower doses or less frequently without medical guidance. Your provider can help develop a safe strategy if supply is limited.

Don't Panic

Shortages are temporary. Manufacturing capacity is expanding, and multiple new GLP-1 medications are in development. The situation is improving, even if gradually.

The Future: When Will Shortages End?

Several developments suggest supply will improve:

• Novo Nordisk manufacturing expansion: Billions invested in new production facilities expected to come online in 2025–2027
• New competitors entering the market: Eli Lilly's tirzepatide products, plus pipeline medications from other manufacturers
• Next-generation oral GLP-1s: May reduce demand for injectable products
• FDA regulatory updates: Ongoing evaluation of compounding pharmacy regulations

While exact timelines are uncertain, the combination of expanded manufacturing and new market entrants should gradually ease supply constraints.

Frequently Asked Questions

Can my doctor prescribe a different dose of Ozempic if my usual dose is unavailable?

Yes, your provider can adjust your prescription to an available dose. For example, if your 1.0 mg dose is unavailable, they might prescribe two 0.5 mg pens or transition you to the 2.0 mg dose with adjusted injection volumes. Never attempt to adjust doses on your own — always work with your healthcare provider.

Is compounded semaglutide safe to use during the shortage?

Compounded semaglutide from a reputable, licensed compounding pharmacy can be a reasonable alternative during shortages, but it comes with some additional risk compared to FDA-approved products. Look for 503B outsourcing facilities with third-party testing. Discuss this option with your healthcare provider, who can help evaluate the quality and appropriateness of compounded alternatives.

Will I gain weight if I have to stop Ozempic temporarily due to the shortage?

A temporary gap in treatment may lead to some weight regain, but short interruptions (1–2 weeks) are unlikely to cause significant changes. Longer gaps may result in increased appetite and gradual weight regain. Maintaining strong lifestyle habits during any treatment gap — regular exercise, balanced nutrition, adequate protein — can help minimize regain.

Can I switch from Ozempic to Mounjaro if Ozempic is unavailable?

Yes, switching from Ozempic (semaglutide) to Mounjaro (tirzepatide) is possible with your provider's guidance. They will determine an appropriate starting dose of tirzepatide based on your current semaglutide dose. Many patients have successfully made this transition, and some report equal or better results with tirzepatide.

Are there any non-GLP-1 alternatives for weight loss during the shortage?

Yes, other FDA-approved weight loss medications exist, including phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and orlistat (Xenical/Alli). These work through different mechanisms and generally produce less weight loss than GLP-1 medications, but they may serve as bridges during supply disruptions. Your provider can assess whether any of these alternatives are appropriate for your situation.

Taking the Next Step

The Ozempic shortage can be frustrating, but you have options. Whether it's switching to an available alternative, exploring compounded semaglutide, or adjusting your treatment plan with your provider's guidance, there are pathways to continue your weight management or diabetes treatment journey.

Ready to explore your options? Take our free eligibility quiz →

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.